Who we are
Diversity and Inclusion
Penta ID Network
Penta Foundation Italy
Penta ID Innovation
News & Events
Penta Aperitivo Webinars
Work with us
Call for services
Brighter Future Award
Age and CD4 Count at Initiation of Antiretroviral Therapy in HIV-InfectedChildren: Effects on Long-term T-Cell Reconstitution
Early antiretroviral therapy in HIV-1 infected infants, 1996-2008: treatment response and duration of first-line regimens
A comparison of the pharmacokinetics of raltegravir during pregnancy and post-partum
Long Term consequences of planned treatment interruptions in HIV infected children: Results from the TICCH (Treatment Interruption in Children with Chronic HIV-Infection )/PENTA 11 trial.
Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multi-cohort study.
Risk of triple-class virological failure in children with HIV: a retrospective cohort study
First-line antiretroviral therapy initiation with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor combination and switch at higher versus low viral load in HIV-infected children: an open randomised controlled phase 2/3 trial.